Skip to search formSkip to main contentSkip to account menu

CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine

Known as: CTX/DOX/PRED/VCR, ACOP, cyclophosphamide, doxorubicin, prednisone, and vincristine protocol 
National Institutes of Health

Related topics

Related topics

15 relations

Broader (5)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideCyclophosphamide/Doxorubicin/Etoposide/Prednisone/VincristineDoxorubicin

Narrower (3)

CAUP protocolCHOP-14 protocolCHOP-21 protocol
CDE protocol-cyclophosphamide/doxorubicin/etoposideCHOP regimenDoxorubicin HydrochloridePrednisone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Highly dispersible and stable copper terephthalate metal-organic framework-graphene oxide nanocomposite for an electrochemical sensing application.
A highly dispersible and stable nanocomposite of Cu(tpa)-GO (Cu(tpa) = copper terephthalate metal-organic framework, GO… 
Highly Cited
2011
Highly Cited
2011
Crizotinib in anaplastic large-cell lymphoma.
The anaplastic lymphoma kinase (ALK) inhibitor crizotinib has been shown to induce a response in lung cancers in which ALK is… 
Highly Cited
2005
Highly Cited
2005
Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding.
BACKGROUND CHOP is a transcriptional regulator involved in apoptosis caused by endoplasmic reticulum (ER) stress. We previously… 
Highly Cited
2004
Highly Cited
2004
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
PURPOSE Long-term follow-up with updated time to disease progression (TTP) and duration of response (DR) data are presented from… 
Review
2003
Review
2003
Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP Chemotherapy
We sought to identify risk factors associated with the time to febrile neutropenia in patients with intermediate-grade, non… 
Highly Cited
2003
Highly Cited
2003
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.
This study was designed to test the hypothesis that administration of granulocyte colony-stimulating factor (G-CSF; filgrastim… 
Highly Cited
2001
Highly Cited
2001
CueR (YbbI) of Escherichia coli is a MerR family regulator controlling expression of the copper exporter CopA
We have shown that the open reading frame ybbI in the genomic sequence of Escherichia coli K‐12 encodes the regulator of… 
Highly Cited
2001
Highly Cited
2001
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?
The present study aimed to analyse the treatment outcome of four cycles of CHOP (cyclophosphamide-vincristine-doxorubicin… 
Highly Cited
1991
Highly Cited
1991
Copper resistance in Pseudomonas syringae mediated by periplasmic and outer membrane proteins.
Copper-resistant strains of Pseudomonas syringae pathovar tomato accumulate copper and develop blue colonies on copper-containing… 
Highly Cited
1990
Highly Cited
1990
Control of replication of plasmid R1: the duplex between the antisense RNA, CopA, and its target, CopT, is processed specifically in vivo and in vitro by RNase III.
The replication frequency of IncFII plasmids is regulated through the availability of a rate‐limiting protein, RepA. The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)